BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 3940287)

  • 1. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M; Ploska A; Javoy-Agid F; Agid Y
    Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
    Tilson HA; Schwartz RD; Ali SF; McLamb RL
    Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
    Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autoradiographic analysis of cholinergic receptors in mouse brain.
    Pauly JR; Stitzel JA; Marks MJ; Collins AC
    Brain Res Bull; 1989 Feb; 22(2):453-9. PubMed ID: 2706548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.
    Nordberg A; Winblad B
    Neurosci Lett; 1986 Dec; 72(1):115-9. PubMed ID: 3808458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.
    Nordberg A; Nyberg P; Windblad B
    Neurochem Pathol; 1985; 3(4):223-36. PubMed ID: 3831845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics.
    Hellström-Lindahl E; Winblad B; Nordberg A
    Brain Res; 1993 Aug; 620(1):42-8. PubMed ID: 8402197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
    Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
    Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal development of cholinergic enzymes and receptors in mouse brain.
    Fiedler EP; Marks MJ; Collins AC
    J Neurochem; 1987 Sep; 49(3):983-90. PubMed ID: 3612135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of muscarinic and nicotinic binding sites in brain.
    Nordberg A; Larsson C
    Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in binding to muscarinic and nicotinic cholinergic receptors in the chick telencephalon, following passive avoidance learning.
    Mezey S; Székely AD; Bourne RC; Kabai P; Csillag A
    Neurosci Lett; 1999 Jul; 270(2):75-8. PubMed ID: 10462101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus.
    Lerer B; Stanley M; Demetriou S; Gershon S
    J Neurochem; 1983 Dec; 41(6):1680-3. PubMed ID: 6644306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK; Smith CJ; Court JA; Perry RH
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic muscarinic and nicotinic binding by human lymphocytes: differences between peripheral blood cells and cultivated cell lines.
    Grabczewska E; Laskowska-Bozek H; Maśliński W; Ryzewski J
    Int J Tissue React; 1990; 12(5):281-9. PubMed ID: 2098370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats.
    Vige X; Briley M
    Neurosci Lett; 1988 Jun; 88(3):319-24. PubMed ID: 3386878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.